Abnormal protein kinase activities and the corresponding changes in downstream phosphorylation-mediated signaling have been implicated in the onset of tumor formation and cancer progression and have therefore become attractive targets for therapeutic agents for the treatment of cancer and drug resistance36. Here, WEE1 is linked to cancer.